Results 21 to 30 of about 9,998 (176)
Gastro-Oesophageal Reflux in Noncystic Fibrosis Bronchiectasis
Pulmonary Medicine, 2011 The clinical presentation of noncystic fibrosis bronchiectasis may be complicated by concomitant conditions, including gastro-oesophageal reflux (GOR). Increased acidic GOR is principally caused by gastro-oesophageal junction incompetence and may arise ...
Annemarie L. Lee +3 more
doaj +1 more source
Orphanet Journal of Rare Diseases, 2018 Background Prader-Willi syndrome (PWS) is the most common genetic human obesity syndrome and is characterized by hypotonia, endocrine disturbances, hyperphagia, obesity and mild mental retardation.
Ronnaug Saeves +3 more
doaj +1 more source
The microbiome in oesophageal disease – a year in review [PDF]
Microbiota in Health and Disease, 2020 There is an increasing appreciation of the role that the host microbiome plays in the progression of oesophageal diseases. To date, potential relationships between the microbiota and the development of gastro-oesophageal reflux disease, Barrett’s ...
N. Kaakoush
doaj +1 more source
BMC Cancer, 2010 Background Chronic gastro-oesophageal reflux disease and excessive body fat are considered principal causes of Barrett's oesophagus (a metaplastic change in the cells lining the oesophagus) and its neoplastic progression, oesophageal adenocarcinoma ...
Reeves Marina M +3 more
doaj +1 more source
Journal of Minimal Access Surgery, 2021 Introduction: There is a strong association between gastro-oesophageal reflux disease and morbid obesity. Methods: Two hundred and eleven morbidly obese patients operated between September 2007 and June 2017 were retrospectively reviewed.
Amit Bhambri +5 more
doaj +1 more source
Heartburn, gastro-oesophageal reflux disease and non-erosive reflux disease
South African Family Practice, 2016 Reflux is a normal process that occurs in healthy infants, children and adults. Most episodes are short-lived and do not cause bothersome symptoms of complications.
Haley Smith
doaj +1 more source
The management of gastro-oesophageal reflux disease
Australian Prescriber, 2016 If there are no features of serious disease, suspected gastro-oesophageal reflux disease can be initially managed with a trial of a proton pump inhibitor for 4-8 weeks. This should be taken 30-60 minutes before food for optimal effect. Once symptoms are controlled, attempt to withdraw acid suppression therapy.
Charlotte, Keung, Geoffrey, Hebbard
openaire +2 more sources
Infant formula for gastro-oesophageal reflux disease
South African Family Practice, 2012 Thickened infant formula is widely used as a first-line treatment for gastro-oesophageal reflux (GOR) in infants. The use thereof remains controversial, and conflicting evidence exists with regards to its efficiency. The safety of anti-reflux formula has
C.J.W. Owens +2 more
doaj +1 more source
Additional considerations for gastro-oesophageal reflux disease
South African Family Practice, 2016 Gastro-oesophageal reflux disease (GORD) is a common condition worldwide. It is characterised by numerous upper gastrointestinal tract symptoms, but patients mainly present with heartburn and regurgitation.
A. Marais
doaj +1 more source
Optimization of impedance-measured reflux events in GORD utilizing acid exposure time
BMC Gastroenterology, 2020 Background Combining impedance with pH monitoring improves the detection and characterization of gastro-oesophageal reflux (GOR), yet the two modalities frequently differ in GOR quantification.
Anthony J. Horton, Steven B. Clayton
doaj +1 more source